Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

HealthDay News — Racial/ethnic and socioeconomic disparities contribute to frequent emergency department visits for seizures, according to a study published online July 5 in Epilepsia.

Nightly sleep duration greater than 9.9 hours in the first week postconcussion is associated with higher symptom burden among adolescents.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.